bioRxiv Science⌕ Search

Biology subjects

Dansereau, M.-A.

Publications and source records attributed to Dansereau, M.-A..

2 recordsLinked to original sources

Spatiotemporal Gray Matter Plasticity During Chronification of Preclinical Neuropathic Pain

Chronic neuropathic pain is increasingly recognized as a brain disease characterized by time-dependent structural and functional reorganization of key neural circuits. While human imaging studies implicate widespread changes in network connectivity and gray matter density (GMD), animal models enable direct longitudinal mapping of such plasticity. Here, we applied high-resolution structural MRI in a rat model of chronic pain (spared nerve injury, SNI) and quantified GMD changes across 134 brain regions. Dynamic weight bearing analysis confirmed persistent pain in SNI rats, validating the chronic pain phenotype in our experimental cohort. Longitudinal MRI revealed significant GMD alterations in 31 regions, predominantly within limbic, prefrontal, and cingulate circuits, representing 21% of total brain volume. Among this affected volume, over 17% of brain volume demonstrated GMD increases while only ~3% showed GMD decreases, indicating a heterogeneous neuroplastic response. Specifically, the Frontal Association Cortex exhibited an approximate 10% increase in GMD, the Primary Cingular Cortex showed a modest increase of about 2%, and the Amygdalohyppocampic Area demonstrated a ~10% decrease in GMD over 28 days. Primary sensory, parietal, visual, retrosplenial, and temporal cortices remained largely unaffected. No significant changes were observed in healthy animals over the same period, highlighting the specificity of brain reorganization to persistent neuropathic pain. These findings reaffirm the ability of MRI to robustly quantify pain-induced neuroanatomical remodeling but leave open critical questions about the underlying cellular and molecular mechanisms. Future studies integrating histological and molecular approaches are needed to determine the precise substrate and reversibility of these structural changes, with the goal of identifying therapeutic targets to prevent or reverse maladaptive neuroplasticity in chronic.

neuroscience↗

CCR2 silencing in sensory neurons blocks bone cancer progression

The peripheral nervous system contributes to cancer growth, in part by shaping the immunological niche of the tumor. How the nervous system influences bone cancer progression, and whether the underlying neuroimmune pathways can be targeted therapeutically, remain unclear. Here we demonstrate a profound influence of the peripheral nervous system on tumor progression that can be countered by silencing chemokine receptor signaling in sensory neurons. Axotomy of the tumor-innervating femoral nerve inhibits tumor progression in animals bearing bone cancer, whereas intrathecal delivery of the tumor-associated proinflammatory chemokine CCL2 promotes both tumor growth and allodynia. Silencing CCR2 in dorsal root ganglion (DRG) neurons with a newly developed lipid nanoparticle-formulated Dicer-substrate siRNA impedes tumor progression and pathological bone remodeling, and relieves bone cancer-associated pain. Mechanistically, bone cancer drives CCR2-dependent transport of substance P and CGRP along the tumor-innervating femoral nerve, and these neuropeptides expand the tumor-associated macrophage population; silencing CCR2 in DRG neurons normalizes the neuropeptide milieu and ameliorates altered bone remodeling. We thus define a targetable neuroimmune axis that contributes to cancer progression. HighlightsO_LICancer progression activates sensory neurons, driving pain hypersensitivity and neuropeptide release. C_LIO_LIAxotomy of the tumor-innervating femoral nerve impedes tumor progression. C_LIO_LICCL2-CCR2 signaling in DRG neurons promotes pain hypersensitivity and cancer growth. C_LIO_LISilencing CCR2 in the DRG reduces pain hypersensitivity, tumor-associated macrophage numbers and cancer growth. C_LI

neuroscience↗